44 results
8-K
EX-10.1
74dfzuumlep
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.24.1
rc32hs
5 Oct 23
Index to Financial Statements
5:12pm
8-K
EX-10.1
u3at 452k
29 Sep 23
Entry into a Material Definitive Agreement
5:24pm
8-K
EX-10.2
3o0hp73z jz6i2kg
29 Sep 23
Entry into a Material Definitive Agreement
5:24pm
8-K
EX-10.5
0fthw
29 Sep 23
Entry into a Material Definitive Agreement
5:24pm
424B3
8u41 6b48gtc
22 Sep 23
Prospectus supplement
4:08pm
425
EX-10.2
u0l9t
22 Sep 23
Business combination disclosure
12:55pm
8-K
EX-10.2
xhb3rnw22yzt0lq984d0
22 Sep 23
Entry into a Material Definitive Agreement
12:55pm
424B3
83m0r
21 Sep 23
Prospectus supplement
7:31pm
425
EX-10.1
qx998falrbphu7a
19 Sep 23
Business combination disclosure
3:52pm
8-K
EX-10.1
ahk2udaks
19 Sep 23
Entry into a Material Definitive Agreement
3:51pm